Meniere. Ménière disease
Conditions
Interventions
Intervention 1: Intrevention group 1: 41 patients with definite Meniere intratympanic methyl prednisolone injections at the clinic undergoing local anesthesia for intratympanic. Intervention 2: Interv
Treatment - Drugs
Intrevention group 1: 41 patients with definite Meniere intratympanic methyl prednisolone injections at the clinic undergoing local anesthesia for intratympanic.
Intervention group 2: 41 patients with definite Meniere intratympanic dexamethasone injections at the clinic undergoing local anesthesia for intratympanic.
Sponsors
Vice Chancellorfor Research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients between 18 and 80 years, did not respond to treatment salt restriction, diuretics and betahistine for three months Exclusion criteria: Disease of neuromuscular system, diseases of the spinal cord and CNS disease of the middle ear, otitis media, conductive hearing loss, taking ototoxic, drug addiction, patients with a history of middle ear surgery, surgical intervention in the inner ear, patients by menier bilateral and perforation of the tympanic membrane and absence of systemic corticosteroid treatment
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vertigo. Timepoint: Arrival, 2 to 4 weeks, every 6 weeks for 6 to 12 months. Method of measurement: Audiometery Test and questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hearing. Timepoint: Arrival, 2 to 4 weeks, every 6 weeks for 6 to 12 months. Method of measurement: Audiometry Test.;Tinnitus. Timepoint: Arrival, 2 to 4 weeks, every 6 weeks for 6 to 12 months. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Elham Masoumi
Tehran University of Medical Sciences
Outcome results
None listed